Your browser doesn't support javascript.
loading
The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility.
Liu, Mengyuan; Liu, Xinyi; Suo, Peisu; Gong, Yuan; Qu, Baolin; Peng, Xiumei; Xiao, Wenhua; Li, Yuemin; Chen, Yan; Zeng, Zhen; Lu, Yinying; Huang, Tanxiao; Zhao, Yingshen; Liu, Ming; Li, Lifeng; Chen, Yaru; Zhou, Yanqing; Liu, Guifeng; Yao, Jianfei; Chen, Shifu; Song, Lele.
Afiliação
  • Liu M; HaploX Biotechnology, Co., Ltd., Shenzhen 518057, China.
  • Liu X; HaploX Biotechnology, Co., Ltd., Shenzhen 518057, China.
  • Suo P; HaploX Biotechnology, Co., Ltd., Shenzhen 518057, China.
  • Gong Y; The Second Medical Center of the Chinese PLA General Hospital, Beijing 100853, China.
  • Qu B; The Second Medical Center of the Chinese PLA General Hospital, Beijing 100853, China.
  • Peng X; The Fourth Medical Center of the Chinese PLA General Hospital, Beijing 100037, China.
  • Xiao W; The Fourth Medical Center of the Chinese PLA General Hospital, Beijing 100037, China.
  • Li Y; The Eighth Medical Center of the Chinese PLA General Hospital, Beijing 100091, China.
  • Chen Y; The Fifth Medical Center of the Chinese PLA General Hospital, Beijing 100039, China.
  • Zeng Z; The Fifth Medical Center of the Chinese PLA General Hospital, Beijing 100039, China.
  • Lu Y; The Fifth Medical Center of the Chinese PLA General Hospital, Beijing 100039, China.
  • Huang T; HaploX Biotechnology, Co., Ltd., Shenzhen 518057, China.
  • Zhao Y; HaploX Biotechnology, Co., Ltd., Shenzhen 518057, China.
  • Liu M; HaploX Biotechnology, Co., Ltd., Shenzhen 518057, China.
  • Li L; HaploX Biotechnology, Co., Ltd., Shenzhen 518057, China.
  • Chen Y; HaploX Biotechnology, Co., Ltd., Shenzhen 518057, China.
  • Zhou Y; HaploX Biotechnology, Co., Ltd., Shenzhen 518057, China.
  • Liu G; HaploX Biotechnology, Co., Ltd., Shenzhen 518057, China.
  • Yao J; HaploX Biotechnology, Co., Ltd., Shenzhen 518057, China.
  • Chen S; HaploX Biotechnology, Co., Ltd., Shenzhen 518057, China.
  • Song L; HaploX Biotechnology, Co., Ltd., Shenzhen 518057, China.
Transl Lung Cancer Res ; 9(3): 646-658, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32676327
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Lung Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Lung Cancer Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China